Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20
  • There is currently no data for OSI

Significant contract extension

3 Aug 2022 07:00

RNS Number : 6865U
Osirium Technologies PLC
03 August 2022
Β 

3 August 2022

Β 

Osirium Technologies plc

("Osirium" or the "Group")

Β 

Significant contract extension

Β 

Continued commitment extends Osirium PAM usage for a further three years

Β 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity and IT automation software, is pleased to announce that it has agreed a three-year Privileged Access Management ("PAM") licence extension with an existing customer (the "Customer"), a leading global asset manager, with a total value of c. Β£0.5 million. This extension represents c. 30% of the total bookings achieved by the Group in 2021. The Customer, who has been using Osirium's PAM solution for six years, has committed to use PAM to protect 4,500 devices for another three years.

Β 

In line with the Group's SaaS business model, the full licence fee is payable at the outset and will be reflected in bookings and cash in the current financial year, with revenue being recognised over the three-year term, further underpinning management expectations for the current year.

Β 

In addition to the PAM renewal, the Customer also recently extended the use of the Group's Privileged Process Automation ("PPA") solution for a further 12 months. Since the customer first adopted the PPA solution in 2019, the user licence number has increased from 40 to over 75.

Β 

David Guyatt, Chief Executive Officer, commented: "We are delighted to have agreed this extension, which continues our partnership for another three years and reflects the value of our solutions in protecting mission-critical enterprise systems. Over the time of our engagement, the Customer has also adopted our PPA capability, demonstrating the potential of our 'land and expand' strategy and the trend toward combining automation and security solutions to deliver enhanced security functionality, in line with our product strategy."

Β 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Rupert Hutton, CFO

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

William Ellis Hancock

Β 

About Osirium TechnologiesΒ Plc

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

Β 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

Β 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTPTMPTMTMMBJT
Date   Source Headline
16th Mar 20225:50 pmRNSHolding(s) in Company
14th Mar 20224:40 pmRNSSecond Price Monitoring Extn
14th Mar 20224:35 pmRNSPrice Monitoring Extension
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
10th Mar 20222:16 pmRNSHolding(s) in Company
10th Mar 202211:06 amRNSSecond Price Monitoring Extn
10th Mar 202211:00 amRNSPrice Monitoring Extension
10th Mar 202210:50 amRNSHolding(s) in Company
7th Mar 20224:44 pmRNSHolding(s) in Company
7th Mar 202212:15 pmRNSResult of General Meeting
2nd Mar 20227:00 amRNSNew Customer Wins
1st Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20225:00 pmRNSTotal Voting Rights
18th Feb 20222:52 pmRNSHolding(s) in Company
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202210:30 amRNSProposed Placing and Subscription and Notice of GM
14th Jan 20227:01 amRNSTrading Update
14th Jan 20227:00 amRNSChange of Adviser
29th Nov 20217:00 amRNSTrading Update
8th Nov 20217:00 amRNSChannel Partner and Marketing Update
28th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSRelease of findings from Osirium Ransomware Index
20th Aug 20217:00 amRNSChange of Auditor
22nd Jul 20212:30 pmRNSResult of AGM
11th Jun 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSTotal Voting Rights
21st May 20214:00 pmRNSHolding(s) in Company
20th May 20219:05 amRNSHolding(s) in Company
19th May 20214:24 pmRNSHolding(s) in Company
12th May 20215:16 pmRNSResults of General Meeting
4th May 20217:00 amRNSTotal Voting Rights
30th Apr 202112:43 pmRNSHolding(s) in Company
29th Apr 20216:30 pmRNSHolding(s) in Company
29th Apr 20216:29 pmRNSHolding(s) in Company
27th Apr 20217:00 amRNSPublication of Circular & Notice of GM
23rd Apr 20217:00 amRNSResult of Placing and Subscription & TVR
22nd Apr 20214:41 pmRNSProposed Placing and Subscription & Notice of GM
11th Mar 20217:00 amRNSNHS Trust Customer Wins
1st Feb 20217:00 amRNSNew Patent Granted
15th Jan 20217:00 amRNSTrading Update
9th Dec 20207:00 amRNSContract win with additional UK Ambulance Service
4th Dec 20207:00 amRNSGrant of Options
2nd Dec 202011:05 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSContract win with major UK communications provider
10th Nov 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.